A transparent polymer implant with a dense array of graphene electrodes on the brain’s surface provided information about deep neural activity in transgenic mice. (Nature Nanotechnology)
Audio-visual recordings of seven toddlers with unexplained sudden deaths suggested the deaths were related to convulsive seizures. (Neurology)
Chronic conditions like Alzheimer’s and Parkinson’s disease need alternative payment models due to their increasing prevalence and disproportionate effect on patients, experts argued. (JAMA Neurology)
Incident prescriptions dispensed for attention deficit-hyperactivity disorder (ADHD) surged during the COVID-19 pandemic. (JAMA Psychiatry)
The FDA approved BrainSee, a software platform that combines MRI and cognitive assessments to predict likelihood of progression to Alzheimer’s dementia, Darmiyan announced.
The agency also said yes to immune globulin infusion 10% with recombinant human hyaluronidase (Hyqvia) as maintenance therapy for chronic inflammatory demyelinating polyneuropathy, according to Takeda.
Cognitive reverters — people whose cognitive status changes from impaired to normal — are common in aging and dementia studies. Here’s what predicts reversion. (Alzheimer’s and Dementia)
Preclinical Alzheimer’s participants had immediate intrusive thoughts and distress when they learned they had elevated amyloid levels. (Neurology: Clinical Practice)
Transcriptomic profiling of more than 315,000 cells in the human substantia nigra identified diverse neuron types linked with Parkinson’s disease. (Science Advances)
Nucleus accumbens dopamine release was greater for pair-bonded vole partners than unknown voles. (Current Biology)
Please enable JavaScript to view the